Drug intelligence / Profile preview

morus nigra

Development stage
Unknown
Lead developer
Inonu University
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

*Morus nigra*, commonly known as the black mulberry, is a botanical extract being investigated for its therapeutic potential in oral health, specifically for the treatment of periodontal diseases. In clinical research, it is formulated as a mouthwash and used as an adjunct to non-surgical periodontal treatments such as scaling and root planing (SRP). The extract is noted for its antimicrobial properties against subgingival plaque pathogens, including red complex bacteria and *Fusobacterium*. Additionally, it exhibits anti-inflammatory effects by modulating the levels of pro-inflammatory cytokines in the gingival crevicular fluid, specifically reducing tumor necrosis factor-alpha (TNF-α) and interleukin-1 beta (IL-1β), while potentially increasing anti-inflammatory markers like interleukin-10 (IL-10).

Other names
black mulberrykaradut
02

Targets

IL10 (Interleukin-10)TNFA (Tumor necrosis factor alpha (soluble))IL1B (Interleukin-1 beta)

Beyond the preview

Go deeper on morus nigra.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on morus nigra.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call